AI
LGND icon

Acuitas Investments’s Ligand Pharmaceuticals LGND Stock Holding History

Acuitas Investments’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,494
Closed -$2.39M – 26
2025
Q3 		$2.39M Sell
13,494
-6,403
-32% -$952K 1.53% 34
2025
Q2 		$2.26M Sell
19,897
-7,615
-28% -$814K 1.8% 27
2025
Q1 		$2.89M Hold
27,512
– – 2.46% 16
2024
Q4 		$2.95M Sell
27,512
-12,749
-32% -$1.44M 2.42% 20
2024
Q3 		$4.03M Sell
40,261
-14,421
-26% -$1.45M 1.8% 14
2024
Q2 		$4.61M Hold
54,682
– – 2.47% 6
2024
Q1 		$4M Buy
54,682
+6,979
+15% +$515K 2.02% 9
2023
Q4 		$3.41M Buy
+47,703
New +$2.82M 1.78% 11

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Acuitas Investments's LGND Position: Q4 2025 in Review

Acuitas Investments sold out of Ligand Pharmaceuticals (LGND) in Q4 2025, closing a stake of 13,494 shares — an estimated $2.39M sold.

Acuitas Investments first reported a position in LGND in Q4 2023 and held it in 8 quarters. The position peaked at $4.61M in Q2 2024. 349 funds tracked by Wall St. Rank hold LGND as of Q4 2025.

  • Acuitas Investments reported no remaining Ligand Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Acuitas Investments sold 13,494 Ligand Pharmaceuticals shares in Q4 2025, an estimated $2.39M.
  • Acuitas Investments first reported a position in Ligand Pharmaceuticals in Q4 2023 and held it in 8 quarters.
  • Acuitas Investments's Ligand Pharmaceuticals position peaked at $4.61M in Q2 2024.
  • 349 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2025.

Based on Acuitas Investments's 13F filing for Q4 2025, filed 27 Jan 2026.